DETECTION OF CARDIAC AMYLOIDOSIS, AND MORE, USING SPECT/CT IMAGING OF TECHNETIUM-99M-LABELED PEPTIDE p5+14 (AT-05) Mar 31, 2025
AUTOMATED QUANTIFICATION OF AL AND ATTR SYSTEMIC AMYLOID BURDEN USING 124I-EVUZAMITIDE, A NOVEL PAN-AMYLOID RADIOTRACER Mar 31, 2025
RELIABILITY OF 124I-EVUZAMITIDE IMAGING AND QUANTITATIVE AGREEMENT IN PATIENTS WITH AL AND ATTR SYSTEMIC AMYLOIDOSIS Mar 31, 2025
DIAGNOSTIC PERFORMANCE OF CARDIAC AND WHOLE-BODY 124I-EVUZAMITIDE (AT-01) PET/MRI IN SYSTEMIC AMYLOIDOSIS Mar 29, 2025
Clinical Trial Design of AT-02 Phase 2 Open-Label Extension Study in Systemic Amyloidosis May 29, 2024
